Achieve Life Sciences, Inc. Interest Payable
Achieve Life Sciences, Inc. (ACHV) had Interest Payable of $2.94 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2025-03-11
- 2024-06-30: Interest Payable $2.94M.
- 2024-03-31: Interest Payable $2.62M.
- 2023-12-31: Interest Payable $2.31M.
- 2023-09-30: Interest Payable $2.01M.
| Period end | Interest Payable |
|---|---|
| 2024-06-30 | $2.94M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.62M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.31M 10-K · filed 2025-03-11 |
| 2023-09-30 | $2.01M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.72M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.42M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.14M 10-K · filed 2024-03-28 |
| 2022-09-30 | $847.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $560.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $288.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $29.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |